HYDERABAD, India, May 20, 2013 (DNA : DAILY NEWS & ANALYSIS (INDIA)) - Consumers may celebrate the new drug price control order (DPCO), which was...
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients SANTA CLARA, Calif. --(...
Vortioxetine clinical phase III data show significant improvement in symptoms of major depression Takeda and Lundbeck present results from pivotal...
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb for violating the Animal Welfare...
FDA OKs Generics Of Novartis' Lamisil (Bloomberg News)
Walgreen To Pay $761M For Option Care (Yahoo/Reuters)
Abraxis Will Spin Off Generic Unit (Bloomberg News)
Amgen Paid Lobbying $60K For Medicare Help (Yahoo/AP)
AstraZeneca Sells French Plant To Contract Manufacturer (OutsourcingPharma.com)
